Global Endometrial Cancer Market Size

Statistics for the 2023 & 2024 Global Endometrial Cancer market size, created by Mordor Intelligence™ Industry Reports. Global Endometrial Cancer size report includes a market forecast to 2029 and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of Global Endometrial Cancer Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Endometrial Cancer Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 4.90 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Endometrial Cancer Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Endometrial Cancer Market Analysis

The endometrial cancer market is expected to register a CAGR of 4.9% during the forecast period.

The COVID-19 pandemic had a moderate impact on the endometrial cancer market due to the reduction in patient visits for diagnosis during the initial phases of the COVID-19 pandemic. As per a study published in January 2022 in PubMed, the corona outbreak correlated with the disruption of screening activities and diagnostic assessments.

Endometrial cancer (EC) is one of the most common gynecological malignancies, and it is often detected at an early stage because it frequently produces symptoms. The data suggested that the COVID-19 pandemic had a significant impact on the characteristics and patterns of care of EC patients. However, post-pandemic, the market is anticipated to witness growth due to a rise in the incidence of endometrial cancer cases, an increase in healthcare expenditure, and technological advancements in endometrial cancer diagnosis and treatment.

For instance, as per a September 2022 update from Cancer Australia, an estimated 3,343 new cases of uterine cancer were diagnosed in Australia in 2022. Similarly, as per a Canadian Cancer Society May 2022 update, an estimated 8,100 Canadian women were likely to be diagnosed with uterine cancer in 2022. As per a May 2021 update from the Mayo Clinic, endometrial cancer begins in the layer of cells that form the lining (endometrium) of the uterus. Endometrial cancer is sometimes called uterine cancer.

Moreover, the rise in awareness programs and collaboration relating to endometrial cancer is anticipated to boost market growth. For instance, in March 2021, Eisai Inc. launched an initiative called 'Spot Her' to end the silence around endometrial cancer and inspire women to listen, advocate, and put their health and the health of other women first. The initiative was conducted in partnership with SHARE Cancer Support (SHARE), Facing Our Risk of Cancer Empowered (FORCE), and Black Health Matters. Moreover, in November 2021, the UNC Lineberger Comprehensive Cancer Center launched the Endometrial Cancer Center of Excellence to advance the scientific understanding of the causes, prevention, and clinical treatment of endometrial cancer and aid researchers in discovering the underlying factors that contribute to why black women in North Carolina are twice as likely to die from endometrial cancer. Such developments spread awareness about endometrial cancer, thereby boosting the demand for the endometrial cancer treatment market.

Factors, such as those mentioned above play a big role in boosting the market growth. But, the high cost associated with the treatment, the adverse effects of the treatment, and the high toxicity of drugs can be a hindrance.

Endometrial Cancer Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)